New insights could lead to a better pneumococcal vaccine

Sep 22, 2008

Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). The findings, published in the open-access journal PLoS Pathogens on September 19, may aid the development of novel pneumococcal vaccines. (The current vaccine, Prevnar, is expensive and covers only 7 of the 91 known pneumococcal strains.)

Pneumococcus causes serious infections in children and the elderly, including pneumonia and meningitis (inflammation of the brain). Since 2000, U.S. infants have been routinely immunized against pneumococcus, but most developing countries (where nearly one million children die from pneumococcal infections annually) cannot afford the existing vaccine.

Richard Malley, MD, of Children's Division of Infectious Diseases, and Marc Lipsitch, D. Phil., of HSPH have been studying how natural immunity against pneumococcus develops, and have shown that in addition to antibodies, T-cells can provide broad protection against this pathogen. In this new study, Malley and Lipsitch identify the specific protective T-cells – so-called TH17 cells – and show that they protect against infection by releasing IL-17, a protein that enables human blood cells to kill pneumococcus in the nose more efficiently. This is significant, since colonizing a person's nose is the first necessary step of infection.

Researchers had known that children, as they get older, carry pneumococcus in the nose for shorter periods of time and have less risk of disease, but it hadn't been known how this resistance develops. Malley, Lipsitch and their colleagues now show that adults and older children, but not newborn babies, have TH17 cells that target pneumococci, suggesting that exposure to pneumococcus normally leads to production of these cells. In mice, they show directly that exposure to pneumococcus triggers the development of these T cells and shortens the duration of nasal carriage of the pathogen.

The investigators also describe an efficient way of measuring TH17 cells, which could help determine whether a new vaccine is rallying an effective response. "We are now evaluating vaccine candidates and changing them so they not only induce antibodies, but also induce this specific type of immunity," says Malley. "A vaccine that induces both protective antibodies and T-cell immunity to pneumococcus may be a very effective way to protect against this potentially devastating disease."

Malley's own lab is developing an inexpensive whole-cell pneumococcal vaccine that elicits a robust TH17 response in mice. With support from the Program for Appropriate Technology in Health (PATH), a nonprofit group funded in part by the Bill and Melinda Gates Foundation, the vaccine is being manufactured for future human testing by Instituto Butantan, a manufacturer in Brazil. Malley's laboratory is testing various forms of the vaccine in animals, including nasal and oral versions. The advantage of a whole-cell vaccine is that it can broadly protect against all pneumococcal strains and would be very inexpensive to produce and administer.

Malley believes the ability to induce protective T-cell responses may have relevance for other infections of childhood, such as Staphylococcus aureus and Haemophilus influenzae. Such responses are also being evaluated in pathogens against which antibodies are ineffective, such as herpes simplex, malaria and tuberculosis.

Source: Children's Hospital Boston

Explore further: New compounds protect nervous system from the structural damage of MS

add to favorites email to friend print save as pdf

Related Stories

Boy or girl? Lemur scents have the answer

27 minutes ago

Dozens of pregnancy myths claim to predict whether a mom-to-be is carrying a boy or a girl. Some say you can tell by the shape of a woman's bump, or whether she craves salty or sweet.

SOHO sees something new near the sun

2 hours ago

An unusual comet skimmed past the sun on Feb 18-21, 2015, as captured by the European Space Agency (ESA) and NASA's Solar and Heliospheric Observatory, or SOHO.

Train car design reduced impact in Southern California crash

2 hours ago

(AP)—After a horrific crash a decade ago that killed 11 people and injured 180 more, Southern California's commuter train network began investing heavily in passenger cars designed to protect passengers from the full force ...

Appeals court considering warrantless cellphone tracking

2 hours ago

(AP)—Now that the cellphone in your pocket can be used to track your movements, federal appeals judges in Atlanta are considering whether investigators must get a search warrant from a judge to obtain cellphone tower tracking ...

Recommended for you

Mystery of the reverse-wired eyeball solved

Feb 27, 2015

From a practical standpoint, the wiring of the human eye - a product of our evolutionary baggage - doesn't make a lot of sense. In vertebrates, photoreceptors are located behind the neurons in the back of the eye - resulting ...

Neurons controlling appetite made from skin cells

Feb 27, 2015

Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight ...

Quality control for adult stem cell treatment

Feb 27, 2015

A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients. The approach involves a clonal strategy where stem cells are collected ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.